ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

In Brief: Guide Is Late, So RFP Deadline Extended; Real Cancer Mortality Increase Was .7%

January 28, 1977

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012

Variation in Breast Density May Be Strong Risk Factor

July 27, 2012

Hrushesky To Pursue Chronobiology Work At Albany, Forms Group

April 28, 1989